RCT | Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis.
25 Oct, 2022 | 13:19h | UTCCommentary: Successful retreatment of axSpA flare feasible following ixekizumab withdrawal – medwire News